Abstract: Disclosed are a compound, a stereisomer and a tautomer thereof, a pharmaceutically acceptable salt thereof, and a solvate or a prodrug thereof, which can be used for preventing or treating a ROR? mediated disease. The compound has the structural formula (I).

Abstract: The present invention relates to a compound inhibiting the activities of Bruton's tyrosine kinase (BTK) and/or Janus kinase 3 (JAK3), a pharmaceutical composition of the compound, pharmaceutical applications of same, a method for using the compound in inhibiting the activities of BTK and/or JAK3, and a method for using the compound in treatment and/or prevention of BTK- and/or JAK3-mediated diseases or disorders in mammals (especially human). The compound is as represented by structural formula (I).

Abstract: Provided is a random access method of a node, the method including receiving spatial group information on spatial groups generated in a cell from a base station, identifying a spatial group corresponding to the node based on the spatial group information, transmitting a preamble signal to the base station by generating the preamble signal, and receiving a random access response message in response to the preamble signal.

Abstract: The present invention relates to a photosensitive resin composition and a photosensitive material comprising the same. The photosensitive resin composition according to an exemplary embodiment of the present invention may comprise two multi-functional monomers where structures of side chains comprising unsaturated double bonds are different from each other while a composition ratio is changed. Accordingly, in the exemplary embodiment of the present invention, processability is excellent, and it is possible to decrease defects by a rupture when a LCD substrate is sealed and substrate separation defects due to an impact to the LCD products by improving an adhesion property to a lower substrate after a hard baking process.

Abstract: A silicone-containing compound is an additive for a lithium secondary battery electrolyte for improving high-temperature lifetime characteristics and/or high-temperature stability of a lithium secondary battery. An electrolyte for a lithium secondary battery includes the silicon-containing compound. A lithium secondary battery includes the electrolyte. A method of preparing the silicon-containing compound is also provided.

Abstract: A polymer electrolyte for a lithium secondary battery includes a polymer represented by Formula 1 below, wherein a and b are each independently an integer from 1 to 5, and n is an integer from 1 to 1,000. A lithium secondary battery includes the polymer electrolyte.

Abstract: Disclosed is an apparatus and method for estimating a SOC of a secondary battery containing a blended cathode material. The SOC estimating apparatus estimates a SOC of a secondary battery including a cathode having a blended cathode material containing a first cathode material and a second cathode material with different operating voltage ranges, an anode having an anode material, and a separator for separating the cathode from the anode, and the apparatus includes a sensor configured to measure a discharge inception voltage and a final discharge voltage when the secondary battery is discharged for a predetermined time, and a control unit configured to estimate SOC of the secondary battery corresponding to the measured discharge inception voltage and the measured final discharge voltage by using a predetermined relationship between the discharge inception voltage and the final discharge voltage and the SOC of the secondary battery.

Abstract: Disclosed is an apparatus and method for estimating a parameter of a secondary battery. The apparatus includes a sensor unit configured to repeatedly measure a voltage of a secondary battery including a blended cathode material containing at least first and second cathode materials at time intervals when the secondary battery is in an operation state or in an idle state, and a control unit configured to receive the repeatedly measured plurality of voltages from the sensor unit, identify an inflection point in a voltage change profile corresponding to the plurality of voltages, and estimate a depth of discharge (DOD) of the secondary battery by using a voltage measured after the inflection point is identified as a reference voltage.

Abstract: A method for estimating an SOC-OCV profile by degradation of a secondary battery according to an embodiment of the present disclosure includes individually obtaining an SOC-OCV profile (a first profile) of a cathode of the secondary battery and an SOC-OCV profile (a second profile) of an anode of the secondary battery using a half cell; obtaining a new SOC-OCV profile (a third profile) of the cathode by reflecting a level of degradation (a %) by use of the secondary battery to modify the SOC-OCV profile of the cathode, but setting only an SOC range to be narrow in proportion to the level of degradation while maintaining an OCV range of the cathode as it is; obtaining a new SOC-OCV profile (a fourth profile) of the anode by migrating the SOC-OCV profile of the anode in a horizontal direction taking into account the level of degradation by use of the secondary battery; and obtaining a new SOC-OCV profile (a fifth profile) by determining a subtraction of an OCV value by the SOC-OCV profile of the anode from an O

Abstract: A resistance factor determining method of a secondary battery according to the present disclosure determines, when the secondary battery has a certain temperature and state of charge, a primary differential value regarding a charge initial I-V profile calculated from a current value at a point of intersection at which a charge final I-V profile according to changes in magnitude of the charging current meets a boundary line set to a charge upper limit as the resistance factor corresponding to the temperature and state of charge. Further, a charge power estimating apparatus and method according to the present disclosure estimates a charge power corresponding to the temperature and state of charge of the secondary battery while the secondary battery is being charged using the resistance factor pre-defined according to the state of charge and temperature of the secondary battery.

Abstract: A method for determining a source and a transmission path to provide content includes receiving a message comprising at least one of channel information of a link between a request device which requests content download and a central management device, available resource amount information of a candidate device, channel information of a link between the candidate device and the central management device, and channel information of a link between the request device and one candidate device. The method also includes determining a source device and the transmission path for providing the content to the request device using an available resource amount of the candidate device, a data rate of the link between the request device and the central management device, a data rate of the link between the request device and the candidate device, and a data rate of the link between the candidate device and the central management device.

Abstract: Provided are an organic electrolytic solution and a lithium battery including the organic electrolytic solution, wherein the organic electrolytic solution includes an organic solvent, a lithium salt, a borate compound represented by Formula 1 below, and an ionic metal complex represented by Formula 2 below: wherein R1, R2, and R3 are each independently a hydrogen; a C1-C5 alkyl group substituted or unsubstituted with a halogen; or a C1-C5 cyanoalkyl group substituted or unsubstituted with a halogen, at least one of the R1, R2, and R3 includes a cyanoalkyl group, Me is an element selected from the group consisting of transition metals and Groups 13 to 15 elements of the periodic table, M is a metal ion, a is an integer from 1 to 3, b is an integer from 1 to 3, s=b/a, p is an integer from 0 to 8, q is 0 or 1, r is an integer from 1 to 4, X1 and X2 are each independently O, S, or NR6, R4 and R6 are each independently a halogen, a C1-C5 alkyl group substituted or unsubstituted with a halogen, or a C1-C5 ary

Abstract: The present disclosure relates to a method and an apparatus for estimating a discharge power of a secondary battery. The method according to the present disclosure includes setting a state of charge of a secondary battery for which estimation of discharge power is intended, discharging the secondary battery with a plurality of discharge currents while measuring a discharge termination voltage corresponding to each of the discharge currents, generating a current-voltage (I-V) profile that at least forms a point of intersection with the preset discharge boundary condition, and determining a discharge power using a current value and a voltage value corresponding to the point of intersection.

Abstract: Disclosed is a method for providing contents in a mobile communication system and apparatus thereof.

Abstract: The present invention provides a bifunctional fusion protein comprising the extracellular region of CTLA4 and an anti-IL-17 antibody, a gene encoding the protein, a vector comprising the gene, a host cell comprising the vector, and a pharmaceutical composition containing the protein.

Abstract: Provided is a compound of formula (I) as a TNIK (Traf2- and NCK-interacting kinase), IKK? (I-kappa-B kinase epsilon) and TBK1 (TANK-binding kinase 1) inhibitor; the compound according to the present invention effectively inhibits TNIK, IKK? and TBK1, and thus is useful not only as an anticancer agent for the treatment of various cancers including colorectal cancer, breast cancer, CNS cancer, colon cancer, non-small cell lung cancer, kidney cancer, prostate cancer, ovarian cancer, uterus cancer, stomach cancer, liver cancer, skin cancer, lung cancer, brain cancer, bladder cancer, esophageal cancer, pancreatic cancer, thyroid cancer, head and neck cancer, squamous cell carcinoma, osteosarcoma, B-cell or T-cell lymphoma, acute or chronic leukemia and multiple myeloma, but as a therapeutic agent for chronic inflammation.

Abstract: The present specification relates to a photoresist resin composition, a touch panel including a bezel pattern manufactured by using the photoresist resin composition, and a display device including the bezel pattern manufactured by using the photoresist resin composition.

Abstract: Provided are 7-azaindole or 4,7-diazaindole derivatives as an IKK? (I-kappa-B kinase epsilon) and TBK1 (TANK-binding kinase 1) inhibitor. The 7-azaindole or 4,7-diazaindole derivative effectively inhibits IKK? and TBK1, and thus is useful not only as an anticancer agent for the treatment of various cancers including colorectal cancer, breast cancer, CNS cancer, colon cancer, non-small cell lung cancer, kidney cancer, prostate cancer, ovarian cancer, uterus cancer, stomach cancer, liver cancer, skin cancer, lung cancer, brain cancer, bladder cancer, esophageal cancer, pancreatic cancer, thyroid cancer, head and neck cancer, squamous cell carcinoma, osteosarcoma, B-cell or T-cell lymphoma, acute or chronic leukemia and multiple myeloma, but as a therapeutic agent for chronic inflammation.

Abstract: Disclosed herein are methods of generating induced pluripotent stem cells. The method involves providing a quantity of somatic or non-embryonic cells, contacting the contacting the somatic or non-embryonic cells with a quantity of one or more reprogramming factors and one or more RNA molecules, and culturing the somatic or non-embryonic cells for a period of time sufficient to generate at least one induced pluripotent stem cell. Various reprogramming factors and RNA molecules for use in the methods are disclosed herein. Also disclosed are cell lines and pharmaceutical compositions generated by use of the methods.

Abstract: The present invention relates to a novel fused pyrimidine derivative having an inhibitory activity for tyrosine kinases, and a pharmaceutical composition for preventing or treating cancers, tumors, inflammatory diseases, autoimmune diseases, or immunologically mediated diseases comprising same as an active ingredient.